Local pharmaceutical industry in transition

The country’s pharmaceutical companies face tough times ahead of the government’s plan to slash drug prices. So far, the government’s tight control over drug pricing and reimbursement policies under the national health insurance scheme has pose a challenge to the industry.

Korean firms remained jittery over how to sustain generic drug sales.

“Given that most Korean firms rely on developin...